Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
Live Audio Webcast Tuesday, September 27, 2005
SAN DIEGO, Sept 26, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Gary Lyons, President and Chief Executive Officer of Neurocrine Biosciences will present an overview of the Company including marketing highlights for indiplon and the Company's broad development pipeline at the UBS Global Life Sciences Conference. The live presentation will take place Tuesday, September 27, 2005 at 12:30PM Eastern Time (ET) / 9:30AM Pacific Time (PT) at the Grand Hyatt New York. The presentation will be simultaneously webcast and can be accessed on the Company's website at http://www.neurocrine.com
If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600 and ask for Claudia Woodworth or Elizabeth Foster. A replay will become available approximately three hours after the live event concludes. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. The presentation will be archived until Tuesday, October 11, 2005.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com
Contact: Claudia Woodworth or Elizabeth Foster at 858-617-7600.
SOURCE Neurocrine Biosciences, Inc.
Claudia Woodworth or Elizabeth Foster, +1-858-617-7600, both of Neurocrine Biosciences, Inc.